Class information for:
Level 1: VORICONAZOLE//POSACONAZOLE//HYDROXYITRACONAZOLE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8574 1239 33.2 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
156 3       MYCOSES//MYCOLOGY//CANDIDA ALBICANS 62026
55 2             CANDIDA ALBICANS//CANDIDA//ASPERGILLOSIS 29629
8574 1                   VORICONAZOLE//POSACONAZOLE//HYDROXYITRACONAZOLE 1239

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 VORICONAZOLE authKW 2148721 24% 29% 300
2 POSACONAZOLE authKW 1065006 10% 34% 129
3 HYDROXYITRACONAZOLE authKW 574444 2% 90% 26
4 ITRACONAZOLE authKW 503805 13% 13% 162
5 THERAPEUTIC DRUG MONITORING authKW 161518 10% 5% 120
6 SCH 56592 authKW 147861 0% 100% 6
7 PFIZER CLIN UNIT address 105050 1% 47% 9
8 GLOBAL ESTABLISHED PHARMA BUSINESS address 78858 0% 80% 4
9 POSACONAZOLE ORAL SUSPENSION authKW 73931 0% 100% 3
10 INVASIVE FUNGAL INFECTION authKW 57163 3% 7% 32

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 10387 53% 0% 659
2 Microbiology 5297 28% 0% 346
3 Infectious Diseases 3977 17% 0% 215
4 Mycology 3600 7% 0% 87
5 Medical Laboratory Technology 1028 5% 0% 62
6 Transplantation 803 6% 0% 70
7 Dermatology 688 6% 0% 76
8 Chemistry, Analytical 214 7% 0% 88
9 Toxicology 204 5% 0% 57
10 Hematology 192 5% 0% 57

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PFIZER CLIN UNIT 105050 1% 47% 9
2 GLOBAL ESTABLISHED PHARMA BUSINESS 78858 0% 80% 4
3 HOME CANC CARE SERV 49287 0% 100% 2
4 NEW S WALES REFERRAL THER EUT DRUG MONITORIN 49287 0% 100% 2
5 DIPARTIMENTO IGIENE MICROBIOL ALESSANDRO 32857 0% 67% 2
6 SECT INFECT DIS MED MICROBIOL IMMUNOL 32857 0% 67% 2
7 MICROBIOL CLIN INFECT DIS 31681 0% 43% 3
8 218 226BH18 24644 0% 100% 1
9 A MADRID CARTAGENA 24644 0% 100% 1
10 ACUTE COMMUNITY PNEUMOL 24644 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 36087 15% 1% 186
2 MYCOSES 20576 4% 2% 50
3 THERAPEUTIC DRUG MONITORING 8503 3% 1% 36
4 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 7520 5% 1% 62
5 PHARMACOTHERAPY 3918 2% 1% 27
6 JOURNAL DE MYCOLOGIE MEDICALE 3390 1% 1% 11
7 TRANSPLANT INFECTIOUS DISEASE 3062 1% 1% 12
8 MEDICAL MYCOLOGY 2965 1% 1% 16
9 INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2809 2% 1% 21
10 CLINICAL PHARMACOKINETICS 2028 1% 1% 14

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 VORICONAZOLE 2148721 24% 29% 300 Search VORICONAZOLE Search VORICONAZOLE
2 POSACONAZOLE 1065006 10% 34% 129 Search POSACONAZOLE Search POSACONAZOLE
3 HYDROXYITRACONAZOLE 574444 2% 90% 26 Search HYDROXYITRACONAZOLE Search HYDROXYITRACONAZOLE
4 ITRACONAZOLE 503805 13% 13% 162 Search ITRACONAZOLE Search ITRACONAZOLE
5 THERAPEUTIC DRUG MONITORING 161518 10% 5% 120 Search THERAPEUTIC+DRUG+MONITORING Search THERAPEUTIC+DRUG+MONITORING
6 SCH 56592 147861 0% 100% 6 Search SCH+56592 Search SCH+56592
7 POSACONAZOLE ORAL SUSPENSION 73931 0% 100% 3 Search POSACONAZOLE+ORAL+SUSPENSION Search POSACONAZOLE+ORAL+SUSPENSION
8 INVASIVE FUNGAL INFECTION 57163 3% 7% 32 Search INVASIVE+FUNGAL+INFECTION Search INVASIVE+FUNGAL+INFECTION
9 AZOLE ANTIFUNGAL DRUGS 56325 0% 57% 4 Search AZOLE+ANTIFUNGAL+DRUGS Search AZOLE+ANTIFUNGAL+DRUGS
10 ASPERGILLOSIS 54500 5% 4% 58 Search ASPERGILLOSIS Search ASPERGILLOSIS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 LAVERDIERE, M , BOW, EJ , ROTSTEIN, C , AUTMIZGUINE, J , BROADY, R , GARBER, G , HAIDER, S , HUSSAINI, T , HUSAIN, S , OVETCHKINE, P , ET AL (2014) THERAPEUTIC DRUG MONITORING FOR TRIAZOLES: A NEEDS ASSESSMENT REVIEW AND RECOMMENDATIONS FROM A CANADIAN PERSPECTIVE.CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY. VOL. 25. ISSUE 6. P. 327 -343 152 72% 5
2 ASHBEE, HR , BARNES, RA , JOHNSON, EM , RICHARDSON, MD , GORTON, R , HOPE, WW , (2014) THERAPEUTIC DRUG MONITORING (TDM) OF ANTIFUNGAL AGENTS: GUIDELINES FROM THE BRITISH SOCIETY FOR MEDICAL MYCOLOGY.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 69. ISSUE 5. P. 1162-1176 94 76% 71
3 CENDEJAS-BUENO, E , CUENCA-ESTRELLA, M , GOMEZ-LOPEZ, A , (2014) CLINICAL INDICATIONS FOR THERAPEUTIC DRUG MONITORING OF ANTIFUNGAL AGENTS. IN THE WAY FOR OPTIMIZING THE TREATMENT OF FUNGAL INFECTION.REVISTA ESPANOLA DE QUIMIOTERAPIA. VOL. 27. ISSUE 1. P. 1 -16 99 75% 0
4 CHAU, MM , KONG, DCM , VAN HAL, SJ , URBANCIC, K , TRUBIANO, JA , CASSUMBHOY, M , WILKES, J , COOPER, CM , ROBERTS, JA , MARRIOTT, DJE , ET AL (2014) CONSENSUS GUIDELINES FOR OPTIMISING ANTIFUNGAL DRUG DELIVERY AND MONITORING TO AVOID TOXICITY AND IMPROVE OUTCOMES IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCY, 2014.INTERNAL MEDICINE JOURNAL. VOL. 44. ISSUE 12B. P. 1364 -1388 126 53% 11
5 HAMADA, Y , TOKIMATSU, I , MIKAMO, H , KIMURA, M , SEKI, M , TAKAKURA, S , OHMAGARI, N , TAKAHASHI, Y , KASAHARA, K , MATSUMOTO, K , ET AL (2013) PRACTICE GUIDELINES FOR THERAPEUTIC DRUG MONITORING OF VORICONAZOLE: A CONSENSUS REVIEW OF THE JAPANESE SOCIETY OF CHEMOTHERAPY AND THE JAPANESE SOCIETY OF THERAPEUTIC DRUG MONITORING.JOURNAL OF INFECTION AND CHEMOTHERAPY. VOL. 19. ISSUE 3. P. 381-392 61 94% 14
6 AZANZA, JR , SADABA, B , GOMEZ-GUIU, A , (2014) PHARMACOLOGY OF THE ANTIFUNGALS USED IN THE TREATMENT OF ASPERGILLOSIS.REVISTA IBEROAMERICANA DE MICOLOGIA. VOL. 31. ISSUE 4. P. 255 -261 77 77% 0
7 JOB, KM , OLSON, J , STOCKMANN, C , CONSTANCE, JE , ENIOUTINA, EY , ROWER, JE , LINAKIS, MW , BALCH, AH , YU, T , LIU, XX , ET AL (2016) PHARMACODYNAMIC STUDIES OF VORICONAZOLE: INFORMING THE CLINICAL MANAGEMENT OF INVASIVE FUNGAL INFECTIONS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 14. ISSUE 8. P. 731 -746 101 56% 0
8 DOLTON, MJ , MCLACHLAN, AJ , (2014) OPTIMIZING AZOLE ANTIFUNGAL THERAPY IN THE PROPHYLAXIS AND TREATMENT OF FUNGAL INFECTIONS.CURRENT OPINION IN INFECTIOUS DISEASES. VOL. 27. ISSUE 6. P. 493 -500 74 73% 9
9 DOLTON, MJ , MCLACHLAN, AJ , (2014) VORICONAZOLE PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS: ASSESSING THE LINKS BETWEEN EXPOSURE, EFFICACY AND TOXICITY.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 44. ISSUE 3. P. 183 -193 71 72% 8
10 KARTHAUS, M , LEHRNBECHER, T , LIPP, HP , KLUGE, S , BUCHHEIDT, D , (2015) THERAPEUTIC DRUG MONITORING IN THE TREATMENT OF INVASIVE ASPERGILLOSIS WITH VORICONAZOLE IN CANCER PATIENTS-AN EVIDENCE-BASED APPROACH.ANNALS OF HEMATOLOGY. VOL. 94. ISSUE 4. P. 547 -556 48 84% 11

Classes with closest relation at Level 1


Rank Class id link
1 781 INVASIVE ASPERGILLOSIS//ASPERGILLOSIS//INVASIVE FUNGAL INFECTION
2 5768 MICAFUNGIN//CASPOFUNGIN//ECHINOCANDINS
3 9484 FLUCONAZOLE//MICRODILUTION TEST//SUSCEPTIBILITY TESTING
4 11732 CYP51A//AZOLE RESISTANCE//ISAVUCONAZOLE
5 20089 BIOORGAN MED CHEM//OPTICALLY ACTIVE ANTIFUNGAL AZOLE//CYP51
6 27807 CLOTRIMAZOLE//KETOCONAZOLE DETERMINATION//TROP SUBTROP FISHERY OURCES UTILIZAT
7 16607 SCEDOSPORIUM APIOSPERMUM//PSEUDALLESCHERIA BOYDII//SCEDOSPORIUM PROLIFICANS
8 16229 FUSARIOSIS//INVASIVE FUSARIOSIS//DISSEMINATED FUSARIOSIS
9 24632 AVIAN ASPERGILLOSIS//AVIARY AIR//GREAT RHEA
10 15464 KETOCONAZOLE//NONLINEAR LIVER BINDING//840 SHERBROOK ST

Go to start page